BIOCRYST PHARMACEUTICALS INC·4

Mar 3, 4:29 PM ET

Frank Steven 4

4 · BIOCRYST PHARMACEUTICALS INC · Filed Mar 3, 2026

Insider Transaction Report

Form 4
Period: 2026-02-27
Frank Steven
Director
Transactions
  • Award

    Common Stock

    [F1]
    2026-02-27$8.75/sh+1,285$11,24418,903 total
Footnotes (1)
  • [F1]Shares of Common Stock issued to the reporting person in lieu of 100% of the quarterly cash Board Member retainer of $11,250.
Signature
/s/ Alane P. Barnes, by power of attorney|2026-03-03

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT